GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lytix Biopharma AS (OSL:LYTIX) » Definitions » Net Investment Income

Lytix Biopharma AS (OSL:LYTIX) Net Investment Income


View and export this data going back to 2021. Start your Free Trial

What is Lytix Biopharma AS Net Investment Income?

Net Investment Income only applies to insurance companies.


Lytix Biopharma AS Business Description

Traded in Other Exchanges
Address
Sandakerveien 138, Oslo, NOR, 0484
Lytix Biopharma AS is a clinical-stage biotech company engaged in developing cancer immunotherapies aimed at activating the patient's immune system to fight cancer. Its products, LTX-401 and LTX-315, are in the pipeline. The company operates in Norway and the USA, majority of revenue is from the USA.